Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP1009832.RACaEnsb5asf__rvpX0JNriDo8QwXvetwGKFTZG7iVQ8k130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009832.RACaEnsb5asf__rvpX0JNriDo8QwXvetwGKFTZG7iVQ8k130_provenance.
• NP988766.RA-Uauma9IPUZXy7xljTQAoHCFJgjcCm1QKhDu44rbMTQ130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP988766.RA-Uauma9IPUZXy7xljTQAoHCFJgjcCm1QKhDu44rbMTQ130_provenance.
• NP988769.RA41ElEWCvdhrX1OXf2lfZrhwkHLf6sFmMqi0Kz0EM9Us130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP988769.RA41ElEWCvdhrX1OXf2lfZrhwkHLf6sFmMqi0Kz0EM9Us130_provenance.
• NP991313.RAwmWZwy9A8C0HoeCeLhvDwgKCd3xvEDj8NcCwy4bzDqU130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991313.RAwmWZwy9A8C0HoeCeLhvDwgKCd3xvEDj8NcCwy4bzDqU130_provenance.
• NP939295.RA8foTZBQNV8ZZ4siI3xV-57t4UbYJYldf_hup3ESeUns130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939295.RA8foTZBQNV8ZZ4siI3xV-57t4UbYJYldf_hup3ESeUns130_provenance.
• NP1010111.RA_dX38-kGHyFRHmQWVq1O5e8zdOHsaZCEoCQxVMI4hts130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010111.RA_dX38-kGHyFRHmQWVq1O5e8zdOHsaZCEoCQxVMI4hts130_provenance.
• NP1010114.RA2q4KF6FDsC2N_XEOvLoK4-eA_mtLR8HeDZLwf__hkUA130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010114.RA2q4KF6FDsC2N_XEOvLoK4-eA_mtLR8HeDZLwf__hkUA130_provenance.
• NP1010165.RA9LDScUB4kcGccID8PgNfMOEnCs1-I1Tt2S5zpS8DFDM130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010165.RA9LDScUB4kcGccID8PgNfMOEnCs1-I1Tt2S5zpS8DFDM130_provenance.
• NP1010168.RA_qoKiJDFsYYSIb-UTApAjfWuq3rnjLGeGOh3R8kIQm8130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010168.RA_qoKiJDFsYYSIb-UTApAjfWuq3rnjLGeGOh3R8kIQm8130_provenance.
• NP1010170.RA1PpUetA_rViMD-eOWuHQdM3zF4yijqfvH0-xO642n7s130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010170.RA1PpUetA_rViMD-eOWuHQdM3zF4yijqfvH0-xO642n7s130_provenance.
• NP1009835.RAa2yIs7DOAUmUigpX9btlLkdCsc0dwoFTYdUfPdBVjMo130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009835.RAa2yIs7DOAUmUigpX9btlLkdCsc0dwoFTYdUfPdBVjMo130_provenance.
• NP1010119.RASbxvWVr3fADQ9_DcAXVryAe6Wkzp5k6vybnh1MtB93c130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010119.RASbxvWVr3fADQ9_DcAXVryAe6Wkzp5k6vybnh1MtB93c130_provenance.
• NP1010219.RAcgRqH2CwlWMDaUZhkOL0_cVqGLfLCNKDRadR-xX2ggg130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010219.RAcgRqH2CwlWMDaUZhkOL0_cVqGLfLCNKDRadR-xX2ggg130_provenance.
• NP991316.RArlhS8cfvdHlZXMoxvC16136uAbvsluEFMzlM9WWWNLU130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991316.RArlhS8cfvdHlZXMoxvC16136uAbvsluEFMzlM9WWWNLU130_provenance.
• NP939290.RAIwRQpYPAWec_J7XmK5pTOXNqiEcMPQNUQV6e5wuQBko130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939290.RAIwRQpYPAWec_J7XmK5pTOXNqiEcMPQNUQV6e5wuQBko130_provenance.
• NP1009827.RAP6h_ahl2kWq7IWlP2fTEaZ5yCHtPXJ358lOD9Xp3a4g130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009827.RAP6h_ahl2kWq7IWlP2fTEaZ5yCHtPXJ358lOD9Xp3a4g130_provenance.
• NP1009830.RAoWPK0-aqdliQYJ9u2Eg-VAuBZND97uHYkCJ6bbleJbo130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009830.RAoWPK0-aqdliQYJ9u2Eg-VAuBZND97uHYkCJ6bbleJbo130_provenance.
• NP1010116.RAtjmKN3-wmIF9w1cp8033RpwWGHxBL2PqFChcEkMiX-Q130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010116.RAtjmKN3-wmIF9w1cp8033RpwWGHxBL2PqFChcEkMiX-Q130_provenance.
• NP1010173.RAuvvEI9YNYUeLNOn3VdcEvMloJ8O2Ve-NLfQYhgsvzhY130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010173.RAuvvEI9YNYUeLNOn3VdcEvMloJ8O2Ve-NLfQYhgsvzhY130_provenance.
• NP1010216.RAhHKuIgRPStzSPZWtlYOERRLtg1wZfyHxxAuU1IbLlow130_assertion description "[We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1010216.RAhHKuIgRPStzSPZWtlYOERRLtg1wZfyHxxAuU1IbLlow130_provenance.